# South Korea Protein Engineering Market

> South Korea Protein Engineering Market Research Report By Type (Instrument, Reagent, Services & Software), By Application (Food & Detergent Industries, Environment, Medical, Biopolymer Production, Nano Biotechnology), By Method (Rational Protein Design, Directed, Evolution), and By End-user (Pharmaceutical & Biotechnology Companies, Contract Engineering Organizations, Academic Research Institutes) -Forecast to 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 11.8%
- **2024:** $ 38.01 Million
- **2025:** $ 42.5 Million
- **2035:** $ 129.68 Million
- **Key Players:** Amgen (US), Genentech (US), Regeneron Pharmaceuticals (US), Bristol-Myers Squibb (US), Eli Lilly and Company (US), Novo Nordisk (DK), Merck & Co. (US), Sanofi (FR), Pfizer (US)

**Report ID:** MRFR/MED/51531-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-korea-protein-engineering-market-53292

---

## Market Summary

## **South Korea Protein Engineering Market Overview**

As per MRFR analysis, the South Korea Protein Engineering Market Size was estimated at 33.99 (USD Million) in 2023.The South Korea Protein Engineering Market is expected to grow from 38(USD Million) in 2024 to 147 (USD Million) by 2035. The South Korea Protein Engineering Market CAGR (growth rate) is expected to be around 13.087% during the forecast period (2025 - 2035).

### **Key South Korea Protein Engineering Market Trends Highlighted**

Growing technological investments and the growing need for therapeutic proteins are driving the South Korean protein engineering market's notable expansion. Through a number of programs, including sponsoring academic research and the establishment of innovation centres to advance protein engineering, the South Korean government has taken the initiative to help the biotechnology and life sciences industries. This has made it easier for industry and academia to work together, which has improved protein design and production techniques. Furthermore, South Korea is seeing a rise in the personalised medicine movement as medical professionals work to create customised treatment plans that address the needs of each patient.

The need for more advanced and efficient protein engineering methods is being driven by this trend towards customisation. Furthermore, research into the creation of more sustainable protein sources and substitutes is being spurred by a greater understanding of the advantages of sustainable practices in the protein industry, which is in line with international sustainability objectives. The creation of biopharmaceuticals and biosimilars, as well as the application of protein engineering in agricultural biotechnology to increase crop output and resilience, are generating opportunities in the South Korean industry. The substantial participation of South Korean universities and research institutes is also opening the door for protein engineering innovation and producing a trained workforce ready to spearhead future developments.

In order to increase productivity and effectiveness in research and production, recent developments indicate an emphasis on incorporating artificial intelligence and machine learning into protein design processes. All things considered, government initiatives, technical breakthroughs, and changing market needs are supporting the South Korean protein engineering industry's significant growth.

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

## **South Korea Protein Engineering Market Drivers**

### **Growing Investment in Biopharmaceutical Research**

The South Korea Protein Engineering Market is witnessing significant growth driven by increased investment in biopharmaceutical research. According to the Korean Ministry of Health and Welfare, biopharmaceutical investments have reached over 2.5 trillion Korean Won (approximately 2.2 billion USD) in the last year alone, with the South Korean government aiming to enhance its biopharmaceutical sector's global competitiveness. Major companies such as Samsung Biologics and Celltrion are expanding their capabilities in protein engineering, contributing substantially to the market expansion. This trend towards investment is anticipated to boost innovative research and development initiatives focused on novel therapeutic proteins, enabling the South Korea Protein Engineering Market to thrive. With a focus on precision medicine, the number of clinical trials in biopharmaceuticals is expected to double in the next five years, facilitating advancements that can significantly elevate market valuations.

### **Rising Demand for Targeted Therapies**

There is a growing demand for targeted therapies and personalized medicine in South Korea, which significantly influences the South Korea Protein Engineering Market. According to the National Cancer Center of South Korea, the incidence of cancer is projected to rise by 25% by 2030, driving the need for innovative protein-based therapies that cater to specific patient profiles. Established companies like Hanmi Pharmaceutical are actively involved in developing targeted therapies that utilize protein engineering techniques to enhance treatment efficacy. This increasing prevalence of chronic diseases necessitates advanced biologics, providing a robust platform for the expansion of protein engineering applications in South Korea.

### **Technological Advancements in Protein Engineering**

Technological advancements in protein engineering are bolstering the growth of the South Korea Protein Engineering Market. The Institute for Basic Science has reported a growth in the number of patents related to protein engineering emerging from South Korea, with over 300 applications filed in the last year alone. Companies like LG Chem are leveraging these technological advancements to enhance the efficiency and scalability of protein production processes. Such innovations not only streamline the development of therapeutic proteins but also contribute to reduced manufacturing costs, making it an attractive option for biopharmaceuticals in South Korea. Consequently, the continuous improvement of technologies such as CRISPR and machine learning for protein design will further stimulate market growth.

## **South Korea Protein Engineering Market Segment Insights**

### **Protein Engineering Market Type Insights**

The South Korea Protein Engineering Market is witnessing significant growth across various Type segments, which include Instrument, Reagent, Services, and Software. Each of these segments plays a crucial role in driving the advancements within the industry, particularly in Research and Development. Instruments are essential for protein analysis and manipulation, providing the necessary tools for researchers to study biological interactions intricately. This segment is increasingly adopting advanced technologies, which improve accuracy and efficiency in experimental procedures. Reagents, being vital for biochemical reactions, serve as the foundation for numerous applications in protein engineering. Their availability and development directly influence research productivity and the ability to explore new therapeutic avenues.

The Services segment, which encompasses essential support and expertise, is becoming indispensable as biotech companies seek to outsource complex protein engineering tasks to enhance efficiency and reduce costs. Finally, the Software segment is increasingly impactful, as it allows for streamlined data analysis and enhanced modeling capabilities, facilitating better decision-making processes in protein design. The integration of these segments aligns well with the growing demand for innovative solutions in pharmaceuticals, biotechnology, and academic research within South Korea. Market trends indicate that with the government’s strong support for biotechnological advancements, particularly through funding initiatives, the landscape will continue to evolve. As a result, the South Korea Protein Engineering Market segmentation demonstrates a collaborative ecosystem where instruments, reagents, services, and software continually advance together, enhancing the overall capabilities of protein research and applications, and expanding the market's potential. This dynamic interplay underscores the importance of a multidisciplinary approach in the South Korean protein engineering landscape, where each segment significantly contributes to the overall efficacy and innovation within the industry.

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

### **Protein Engineering Market Application Insights**

The South Korea Protein Engineering Market, particularly within the Application segment, plays a crucial role in various industries such as Food and Detergent, Environment, Medical, Biopolymer Production, and Nano Biotechnology. Each of these applications contributes significantly to the overall market dynamics. In the Food and Detergent Industries, protein engineering enhances the quality and efficiency of various products, ensuring better performance and sustainability. The focus on environmentally friendly solutions is driving advancements in environmental applications, with engineered proteins offering potential solutions for pollution management and waste reduction. In the Medical field, protein engineering is pivotal for drug development, enabling the creation of targeted therapies and improving patient outcomes. With a growing emphasis on eco-friendly materials, Biopolymer Production benefits from protein innovations that lead to biodegradable solutions, catering to both market demand and regulatory pressures. Meanwhile, Nano Biotechnology represents a cutting-edge field where protein engineering contributes to novel applications in drug delivery systems and diagnostics. Overall, the diverse applications of protein engineering in South Korea are expected to foster growth opportunities as innovations continue to evolve, supporting both industrial and societal needs.

### **Protein Engineering Market Method Insights**

The Method segment of the South Korea Protein Engineering Market showcases various techniques employed in manipulating proteins for specific purposes, with a significant focus on Rational Protein Design and Directed Evolution. Rational Protein Design allows researchers to strategically modify protein structures, improving functionalities and addressing specific industrial needs, thus playing a crucial role in drug development and biotechnology applications. Meanwhile, Directed Evolution enables the rapid generation of protein variants through iterative rounds of mutation and selection, effectively enhancing protein properties to meet evolving market demands. This adaptive methodology is increasingly vital as industries seek more efficient and effective proteins, particularly in pharmaceuticals and agriculture. The growing demand for customized enzymes and therapeutic proteins is expected to propel advancements within this segment, leading to innovative solutions tailored for South Korea's biotechnology landscape. Factors driving this growth include increased investments in Research and Development, as well as a burgeoning interest in synthetic biology, all contributing to the vibrant and competitive nature of the South Korea Protein Engineering Market.

### **Protein Engineering Market End-user Insights**

The End-user segment of the South Korea Protein Engineering Market encompasses various key players fundamental to its growth and development. Pharmaceutical and Biotechnology Companies represent a significant portion of this segment, utilizing protein engineering for drug development and therapeutic applications, thus addressing critical healthcare needs in the region. Contract Engineering Organizations provide essential services, facilitating research and production processes, allowing other entities to focus on core competencies while streamlining workflows. Academic Research Institutes contribute crucial insights and innovation through extensive studies and discoveries, driving advancements in protein engineering technologies. Collectively, these entities are crucial in propelling the South Korea Protein Engineering Market forward, creating opportunities for collaboration, enhancing research capabilities, and improving the overall healthcare landscape. The emphasis on research and development in these sectors is vital, as it fosters technological advancements and paves the way for novel solutions and therapies in the field of protein engineering. With South Korea's increasing investment in biotechnology and healthcare innovations, the End-user segment is positioned for significant growth and transformation.

## **South Korea Protein Engineering Market Key Players and Competitive Insights**

The South Korea Protein Engineering Market presents a dynamic landscape characterized by a blend of robust research and development, regulatory frameworks, and innovative technologies. This market is driven by the increasing demand for biopharmaceuticals, which rely heavily on engineered proteins for therapeutic applications. Various players in this sector are leveraging advancements in recombinant DNA technology, protein modification, and expression systems to enhance their product offerings. The competitive dynamics are shaped by a combination of local biopharmaceutical companies and multinational corporations that are eager to capitalize on the growing health market. As such, businesses in this space are continually adapting to meet the demands of healthcare professionals and patients alike, making the insights into their strategies and market positioning vital for stakeholders.

Medytox is a significant player in the South Korea Protein Engineering Market, leveraging its strong foundation in biopharmaceutical development and manufacturing. The company's strengths lie in its proprietary technologies that focus on producing high-quality therapeutic proteins and its commitment to rigorous scientific research. Medytox has established itself as a trusted name in the region through its expansive portfolio of products, particularly in the field of botulinum toxin and therapeutic proteins. The company has also garnered a reputation for effective collaborations with international research institutions, which enhances its innovation capacity. Furthermore, Medytox’s investment in state-of-the-art production facilities and adherence to stringent regulatory standards further solidify its competitive edge, allowing it to respond efficiently to market demands and maintain a strong presence in South Korea’s protein engineering landscape.

Amgen operates with a significant foothold in the South Korean Protein Engineering Market, known primarily for its groundbreaking biopharmaceuticals that extensively utilize protein engineering techniques. Amgen's key products include monoclonal antibodies and innovative therapies for conditions such as cancer and inflammatory diseases, positioning the company as a leader in providing advanced treatment options within the region. The strength of Amgen lies in its commitment to research and development, continually pushing the boundaries of protein science to deliver more effective and safer therapies. The company has made strategic alliances and acquisitions aimed at bolstering its capabilities and expanding its influence in South Korea. By leveraging local partnerships and employing a thorough understanding of the regulatory landscape, Amgen enhances its market presence, leading to substantial growth opportunities in the ever-evolving pharmaceutical industry.

### **Key Companies in the South Korea Protein Engineering Market Include**

- Medytox
- Amgen
- SK Bioscience
- Samsung Biologics
- Merck
- Roche
- Gilead Sciences
- Celltrion
- Pharming Group
- Novo Nordisk
- AstraZeneca
- LG Chem
- Hanmi Pharmaceutical
- Green Cross Corporation
- Janssen Biotech

## **South Korea Protein Engineering Market Developments**

The South Korea Protein Engineering Market has been experiencing significant advancements recently. In September 2023, Medytox announced the expansion of its protein engineering capabilities, enhancing its focus on therapeutic proteins and antibodies, which is part of a broader trend among South Korean companies toward innovation in biopharmaceuticals. SK Bioscience has also made strides by collaborating with international researchers to develop more effective vaccines using protein engineering technologies. Furthermore, Samsung Biologics reported a significant increase in production capacity in July 2023 to support growing demand for protein-based therapeutics, signaling a robust growth trajectory for the market. In terms of mergers and acquisitions, Merck's acquisition of active pharmaceutical ingredient capabilities from a South Korean firm in August 2023 solidified its position in the protein engineering domain. Additionally, Gilead Sciences has been expanding partnerships with local laboratories for Research and Development initiatives in South Korea. The South Korean government is actively supportive of biopharma growth, providing funding opportunities aimed at enhancing the competitive edge of companies like Celltrion and LG Chem in the global protein engineering sector. The overall market valuation reflects a growing appetite for innovative solutions and has the potential to significantly impact healthcare outcomes domestically and internationally.

## **South Korea Protein Engineering Market Segmentation Insights**

### **Protein Engineering Market Type Outlook**

- Instrument
- Reagent
- Services & Software

### **Protein Engineering Market Application Outlook**

- Food & Detergent Industries
- Environment
- Medical
- Biopolymer Production
- Nano Biotechnology

### **Protein Engineering Market Method Outlook**

- Rational Protein Design
- Directed
- Evolution

### **Protein Engineering Market End-user Outlook**

- Pharmaceutical & Biotechnology Companies
- Contract Engineering Organizations
- Academic Research Institutes

## Market Drivers

### Advancements in Synthetic Biology

The protein engineering market in South Korea is experiencing a surge due to advancements in synthetic biology. This field enables the design and construction of new biological parts, devices, and systems. As a result, companies are increasingly investing in research and development to create novel proteins with enhanced functionalities. The South Korean government has recognized the potential of synthetic biology, allocating approximately $200 million to support related initiatives. This funding is likely to foster innovation and drive growth in the protein engineering market, as researchers and companies collaborate to develop applications in pharmaceuticals, agriculture, and environmental sustainability.

### Regulatory Support for Biotechnology

Regulatory frameworks in South Korea are evolving to support the protein engineering market. The government is implementing policies that facilitate the approval and commercialization of biotechnological products. This regulatory support is crucial for companies looking to bring innovative protein-based solutions to market. For instance, the Ministry of Food and Drug Safety has streamlined the approval process for biopharmaceuticals, reducing the time to market. Such initiatives are expected to encourage investment in protein engineering, as companies can navigate the regulatory landscape more efficiently, ultimately leading to a more dynamic and competitive market.

### Growing Demand for Biopharmaceuticals

The protein engineering market is significantly influenced by the growing demand for biopharmaceuticals in South Korea. With an increasing prevalence of chronic diseases, the need for effective therapeutic proteins is on the rise. The biopharmaceutical sector is projected to reach a market value of $10 billion by 2026, indicating a robust growth trajectory. This demand is prompting companies to invest in protein engineering to develop more efficient and targeted therapies. As a result, the protein engineering market is likely to expand, driven by innovations in drug design and production processes that enhance the efficacy and safety of biopharmaceuticals.

### Increased Focus on Sustainable Practices

Sustainability is becoming a key driver in the protein engineering market in South Korea. As environmental concerns grow, there is a push for the development of sustainable protein sources and production methods. Companies are exploring engineered proteins that can replace traditional animal-based products, which are often resource-intensive. This shift is supported by consumer demand for eco-friendly alternatives, with a reported 60% of South Koreans willing to pay more for sustainable products. Consequently, the protein engineering market is likely to see increased investment in research aimed at creating sustainable protein solutions that align with both consumer preferences and environmental goals.

### Emergence of Startups and Innovation Hubs

The protein engineering market in South Korea is witnessing a rise in startups and innovation hubs dedicated to biotechnology. These entities are fostering a culture of innovation, attracting talent and investment. The presence of incubators and accelerators is facilitating collaboration between researchers and entrepreneurs, leading to the development of cutting-edge protein engineering solutions. In 2025, it is estimated that over 100 biotech startups will be operational in South Korea, contributing to a vibrant ecosystem. This influx of new ideas and technologies is likely to drive competition and growth in the protein engineering market, as startups introduce novel applications and products.

## Future Outlook

The [Protein Engineering Market](https://www.marketresearchfuture.com/reports/protein-engineering-market-691) in South Korea is projected to grow at 11.8% CAGR from 2025 to 2035, driven by advancements in biotechnology, increasing demand for sustainable solutions, and rising healthcare needs.

**New opportunities:**

- Development of customized protein therapeutics for niche markets.
- Investment in AI-driven protein design platforms to enhance efficiency.
- Expansion of partnerships with academic institutions for innovative research initiatives.

By 2035, the protein engineering market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Type: Instruments (Largest) vs. Reagents (Fastest-Growing)

The South Korea protein engineering market exhibits a diverse distribution of segment values, with Instruments leading in market share due to their critical role in research and development processes. This segment benefits from a constant demand driven by technological advancements and increased investment in biotechnology. Reagents, while smaller in share, are steadily capturing attention as essential components in protein engineering workflows, marking them as a significant sub-segment within the industry.

Growth trends in the South Korea protein engineering market are influenced by multiple factors including the rising adoption of personalized medicine and advancements in synthetic biology. The demand for Reagents is being propelled by innovative applications and research breakthroughs, making it the fastest-growing segment. Meanwhile, Instruments continue to dominate, driven by ongoing investments and the need for improved research tools, ensuring their position remains robust in the upcoming years.

Instruments: Dominant vs. Reagents: Emerging

Instruments in the South Korea protein engineering market represent the backbone of technological advancement, offering precision and reliability that researchers depend on. This segment encompasses a wide range of devices including spectrometers, chromatographs, and mass spectrometers, which facilitate essential operations in protein analysis and manipulation. On the other hand, Reagents are becoming increasingly important as an emerging segment, driven by innovations in enzyme technologies and molecular biology. As researchers seek to enhance their capabilities in protein engineering, the demand for high-quality Reagents is growing, reflecting their vital role in experiments and thereby reshaping market dynamics.

### By Application: Medical (Largest) vs. Food & Detergent Industries (Fastest-Growing)

In the South Korea protein engineering market, the application segment showcases a diverse utilization across various industries. The Medical sector is currently the largest, driven by increasing investments in healthcare and biotechnology, while the Food & Detergent Industries are rapidly gaining traction as consumers shift towards sustainable and bio-based products. Other segments such as Biopolymer Production, Environment, and Nanobiotechnology also contribute significantly, catering to niche applications and innovative solutions. 

Growth trends indicate a strong upward trajectory, particularly in the Medical and Food & Detergent Industries. Factors such as rising health awareness, regulatory support for biotechnological innovations, and a focus on environmental sustainability are key drivers. The demand for eco-friendly products in food processing and detergent manufacturing is pushing the boundaries of traditional protein engineering, leading to emerging trends that could reshape the market landscape.

Medical: Dominant vs. Food & Detergent Industries: Emerging

The Medical application segment leads the South Korea protein engineering market, characterized by advanced research and significant technological advancements. The dominance in this sector is augmented by rigorous healthcare demands and a constant push for innovation, especially in therapeutic applications. Conversely, the Food & Detergent Industries represent an emerging segment, propelled by consumer preferences for natural and biodegradable products. This sector is witnessing rapid change as companies adapt to new environmental regulations and seek competitive advantages through sustainable practices. Both segments signal a transformational shift in how protein engineering is utilized to address industry-specific challenges.

### By Method: Rational Protein Design (Largest) vs. Directed Evolution (Fastest-Growing)

In the South Korea protein engineering market, Rational Protein Design holds the largest share among the methods employed for developing engineered proteins. This method has gained popularity due to its precise approach in designing proteins with specific functions, resulting in high market acceptance and application in various industries such as pharmaceuticals and biocatalysis. On the other hand, Directed Evolution, although smaller in current market share, is recognized as the fastest-growing method. Its ability to mimic natural selection offers vast potential for innovations, driving increasing investments and research in this area.

The growth trends in the South Korea protein engineering market reflect a strong inclination towards both methodologies. Rational Protein Design continues to benefit from advancements in computational tools, enabling researchers to design proteins with desired characteristics more efficiently. Meanwhile, Directed Evolution is propelled by its practical applications in creating enzymes and other biomolecules for industrial use. The trend indicates a collaborative evolution of these methods, with many companies adopting a hybrid approach for optimized results.

Method: Rational Protein Design (Dominant) vs. Directed Evolution (Emerging)

Rational Protein Design is the dominant methodology in the South Korea protein engineering market, characterized by its systematic approach to understanding protein structure and function. This method leverages computational modeling and simulations, allowing for the targeted design of proteins with specific attributes, making it ideal for high-stakes applications in drug design and therapeutic development. Conversely, Directed Evolution serves as an emerging method, which utilizes iterative cycles of mutations and selections to evolve proteins towards desired functions. This dynamic approach provides flexibility and drives innovation, particularly in biocatalysis and synthetic biology. The distinct advantages of both methods create a competitive landscape where Rational Protein Design maintains a commanding position, while Directed Evolution is on a rapid upward trajectory.

### By End User: Pharmaceutical & Biotechnology Companies (Largest) vs. Contract Engineering Organizations (Fastest-Growing)

In the South Korea protein engineering market, the distribution of market share among end users is predominantly led by pharmaceutical and biotechnology companies, which heavily invest in protein engineering for drug development and therapeutic applications. Following closely are contract engineering organizations that provide essential services, enhancing efficiency for smaller firms and startups in the biotech space. Academic research institutes also play a crucial role but hold a smaller share as they primarily focus on scientific advancements. 

Growth trends in this segment indicate that pharmaceutical and biotechnology companies will continue to thrive as they expand their research and development activities, driven by increasing investments in novel therapies. Simultaneously, contract engineering organizations are emerging as the fastest-growing segment due to rising demand for outsourced services and specialized expertise in protein engineering. This growth is further propelled by the surge in collaborations between academic and industry players.

Pharmaceutical & Biotechnology Companies (Dominant) vs. Contract Engineering Organizations (Emerging)

Pharmaceutical and biotechnology companies dominate the South Korea protein engineering market due to their substantial investment in R&D aimed at enhancing drug discovery and development processes. They leverage advanced techniques in protein engineering to create innovative biologics, which are pivotal in modern therapeutics. This segment benefits from a well-established regulatory framework and strong market demand for biopharmaceuticals. Meanwhile, contract engineering organizations represent an emerging force in this sector, providing critical support through specialized services, enabling smaller companies to access advanced protein engineering technologies without substantial capital expenditure. This flexibility allows for rapid innovation cycles and boosts market competitiveness in the face of scientific challenges.

## Competitive Benchmarking

The [protein engineering](https://www.marketresearchfuture.com/reports/protein-engineering-market-691) market in South Korea is characterized by a dynamic competitive landscape, driven by innovation, strategic partnerships, and a focus on advanced therapeutic solutions. Key players such as Amgen (US), Genentech (US), and Regeneron Pharmaceuticals (US) are at the forefront, leveraging their extensive research capabilities and technological advancements to enhance their market positions. Amgen (US) emphasizes biopharmaceutical innovation, while Genentech (US) focuses on personalized medicine, indicating a trend towards tailored therapeutic approaches. Regeneron Pharmaceuticals (US) appears to be concentrating on expanding its pipeline through strategic collaborations, which collectively shapes a competitive environment that is increasingly focused on specialized and effective protein-based therapies.
In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency and responsiveness to market demands. The competitive structure of the market is moderately fragmented, with several key players exerting substantial influence. This fragmentation allows for a diverse range of products and innovations, yet the presence of major companies ensures that competition remains robust, driving continuous advancements in protein engineering.
In October 2025, Amgen (US) announced a strategic partnership with a leading South Korean biotech firm to co-develop next-generation monoclonal antibodies. This collaboration is significant as it not only enhances Amgen's local presence but also taps into the innovative capabilities of South Korean firms, potentially accelerating the development of novel therapies. Such partnerships are indicative of a broader trend where global companies seek to leverage local expertise to enhance their product offerings.
In September 2025, Regeneron Pharmaceuticals (US) launched a new initiative aimed at integrating artificial intelligence (AI) into its drug discovery processes. This move is crucial as it positions Regeneron at the cutting edge of technology-driven innovation, potentially reducing the time and cost associated with bringing new therapies to market. The integration of AI is likely to enhance the precision of protein engineering, aligning with the industry's shift towards more efficient and targeted therapeutic solutions.
In August 2025, Genentech (US) expanded its research facilities in South Korea, focusing on the development of biosimilars. This expansion reflects a strategic pivot towards addressing the growing demand for cost-effective biologics in the region. By investing in local infrastructure, Genentech not only strengthens its operational capabilities but also demonstrates a commitment to meeting regional healthcare needs, which is increasingly important in a competitive landscape.
As of November 2025, current trends in the protein engineering market include a pronounced emphasis on digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming increasingly pivotal, as companies recognize the value of collaboration in navigating complex market dynamics. Looking ahead, competitive differentiation is likely to evolve, shifting from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition underscores the importance of agility and responsiveness in a rapidly changing market environment.

## Recent News & Developments

The South Korea Protein Engineering Market has been experiencing significant advancements recently. In September 2023, Medytox announced the expansion of its protein engineering capabilities, enhancing its focus on therapeutic proteins and antibodies, which is part of a broader trend among South Korean companies toward innovation in biopharmaceuticals. SK Bioscience has also made strides by collaborating with international researchers to develop more effective vaccines using protein engineering technologies. Furthermore, Samsung Biologics reported a significant increase in production capacity in July 2023 to support growing demand for protein-based therapeutics, signaling a robust growth trajectory for the market. In terms of mergers and acquisitions, Merck's acquisition of active pharmaceutical ingredient capabilities from a South Korean firm in August 2023 solidified its position in the protein engineering domain. Additionally, Gilead Sciences has been expanding partnerships with local laboratories for Research and Development initiatives in South Korea. The South Korean government is actively supportive of biopharma growth, providing funding opportunities aimed at enhancing the competitive edge of companies like Celltrion and LG Chem in the global protein engineering sector. The overall market valuation reflects a growing appetite for innovative solutions and has the potential to significantly impact healthcare outcomes domestically and internationally.

## Report Scope

| MARKET SIZE 2024 | 38.01(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 42.5(USD Million) |
| MARKET SIZE 2035 | 129.68(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 11.8% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Amgen (US), Genentech (US), Regeneron Pharmaceuticals (US), Bristol-Myers Squibb (US), Eli Lilly and Company (US), Novo Nordisk (DK), Merck & Co. (US), Sanofi (FR), Pfizer (US) |
| Segments Covered | Type, Application, Method, End User |
| Key Market Opportunities | Advancements in synthetic biology drive innovation in the protein engineering market. |
| Key Market Dynamics | Rising demand for biopharmaceuticals drives innovation and competition in the protein engineering market. |
| Countries Covered | South Korea |

## Frequently Asked Questions

**Q: What was the market valuation of the protein engineering market in 2024?**
A: The market valuation was $38.01 Million in 2024.

**Q: What is the projected market valuation for 2035?**
A: The projected valuation for 2035 is $129.68 Million.

**Q: What is the expected CAGR for the protein engineering market during the forecast period 2025 - 2035?**
A: The expected CAGR is 11.8% during the forecast period 2025 - 2035.

**Q: Which companies are considered key players in the protein engineering market?**
A: Key players include Amgen, Genentech, Regeneron Pharmaceuticals, and others.

**Q: What are the main segments of the protein engineering market?**
A: The main segments include Type, Application, Method, and End User.

**Q: What was the valuation of the Instruments segment in 2024?**
A: The Instruments segment was valued at $10.0 Million in 2024.

**Q: How much is the Medical application segment projected to grow by 2035?**
A: The Medical application segment is projected to grow from $12.0 Million to $40.0 Million by 2035.

**Q: What is the valuation range for the Directed Evolution method?**
A: The Directed Evolution method has a valuation range from $23.01 Million to $78.68 Million.

**Q: Which end user segment had the highest valuation in 2024?**
A: The Pharmaceutical & Biotechnology Companies segment had the highest valuation at $20.0 Million in 2024.

**Q: What is the projected growth for the Food & Detergent Industries application by 2035?**
A: The Food & Detergent Industries application is projected to grow from $8.0 Million to $27.0 Million by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-protein-engineering-market-53292*